???pagination.result.count???
???pagination.result.page???
1
Targeting cell-bound MUC1 on myelomonocytic, monocytic leukemias and phenotypically defined leukemic stem cells with anti-SEA module antibodies. , Guillaume T, Dehame V, Chevallier P, Peterlin P, Garnier A, Grégoire M, Pichinuk E, Rubinstein DB, Wreschner DH., Exp Hematol. February 1, 2019; 70 97-108.
Determination of ADP-ribosyl cyclase activity, cyclic ADP-ribose, and nicotinic acid adenine dinucleotide phosphate in tissue extracts. , Graeff RM, Lee HC., Methods Mol Biol. January 1, 2013; 1016 39-56.
Signaling properties of CD38 in the mouse immune system: enzyme-dependent and -independent roles in immunity. , Lund FE., Mol Med. January 1, 2006; 12 (11-12): 328-33.
The CD38/cyclic ADP-ribose system: a topological paradox. , De Flora A, Guida L, Franco L, Zocchi E., Int J Biochem Cell Biol. October 1, 1997; 29 (10): 1149-66.
Modulator and messenger functions of cyclic ADP-ribose in calcium signaling. , Lee HC., Recent Prog Horm Res. January 1, 1996; 51 355-88; discussion 389.
Human lymphocyte antigen CD38 catalyzes the production of cyclic ADP-ribose. , Summerhill RJ, Jackson DG, Galione A ., FEBS Lett. December 6, 1993; 335 (2): 231-3.